You just read:

Genoptix Launches FDA-Authorized BCR-ABL MRDx® TFR Monitoring Test for Patients with Chronic Myeloid Leukemia on Tasigna®(nilotinib)

News provided by

Genoptix, Inc.

Sep 04, 2018, 08:30 ET